KRAS and cancer: Similarly to lung, the overall impact of Myc hypomorphism was a profound block in the transition of almost all indolent PanIN pre-tumour lesions to invasive cancer, temporally locating the Myc-dependent bottleneck post initial KRas activation but before the invasive expansion of early cancer.